Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Vascular Care was a U.S. healthcare services company that developed and operated outpatient vascular access centers focused primarily on patients with end-stage renal disease and kidney failure. The company partnered with nephrologists, interventional radiologists, cardiologists, and vascular surgeons to deliver minimally invasive vascular procedures and related ambulatory services. Its service footprint included dialysis access management and broader vascular interventions such as treatment for peripheral arterial disease, venous disease, uterine fibroids, and varicocele. Founded in 2005, the company was acquired in March 2010 by a Fresenius Medical Care subsidiary and was subsequently absorbed into Fresenius' vascular care operations, which today are represented through Azura Vascular Care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Vascular Care.